1604858
USP
卡巴拉汀 酒石酸酯
United States Pharmacopeia (USP) Reference Standard
别名:
ENA-713, N-乙基 -甲基-全氟酸 3-[(1S)-1-(二甲基氨基)乙基] 苯酯 酒石酸酯, 乙基甲基氨基甲酸 3-[(1S)-1-(二甲基氨基)乙基]苯基酯, 酒石酸卡巴拉汀 酒石酸酯
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C14H22N2O2 · C4H6O6
化学文摘社编号:
分子量:
400.42
MDL编号:
UNSPSC代码:
41116107
NACRES:
NA.24
等级
pharmaceutical primary standard
API类
rivastigmine
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
包装形式
neat
储存温度
2-8°C
SMILES字符串
N([C@@H](C)c1cc(ccc1)OC(=O)N(CC)C)(C)C.O[C@@H]([C@H](O)C(=O)O)C(=O)O
InChI
1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1
InChI key
GWHQHAUAXRMMOT-RWALOXMOSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Rivastigmine Tartrate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monograph such as Rivastigmine Tartrate Capsules.
Also, for use with USP monograph such as Rivastigmine Tartrate Capsules.
生化/生理作用
卡巴拉汀是一种口服、脑透过性、可逆的胆碱酯酶抑制剂。
卡巴拉汀是一种口服口服、脑透过性、可逆的胆碱酯酶抑制剂，可增强阿尔茨海默症和帕金森氏病患者的认知功能。卡巴拉汀可同时抑制丁酰胆碱酯酶和乙酰胆碱酯酶。
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
警示用语：
Danger
危险声明
危险分类
Acute Tox. 2 Oral - Aquatic Chronic 2
储存分类代码
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持